$183.60
-5.33 (-2.82%)
Open$188.14
Previous Close$188.93
Day High$188.40
Day Low$182.62
52W High$15,730.00
52W Low$9,573.51
Volume—
Avg Volume1.26M
Market Cap218.85B
P/E Ratio28.62
EPS$6.55
SectorHealthcare
Analyst Ratings
Strong Buy
34 analysts
Key Financials
| FY 2026 | FY 2025 | |
|---|---|---|
| Revenue | 42.85B | 39.02B |
| Net Income | 7.46B | 6.11B |
| Profit Margin | 17.4% | 16.5% |
| EBITDA | 12.99B | 11.23B |
| Free Cash Flow | — | — |
| Rev Growth | +9.8% | +9.8% |
| Debt/Equity | 0.61 | 0.61 |
Dividend
Dividend Yield1.73%
Annual Dividend$3.21
Payout Ratio48.6%
Frequencyquarterly
Ex-Dividend—
Pay Date—
AZN Frequently Asked Questions
What is AZN's stock price today?
AZN last closed at $183.60, down 2.82% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $9,573.51 and a high of $15,730.00. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.
What do Wall Street analysts say about AZN?
Among 34 analysts covering AZN, the consensus rating is Strong Buy — 28 rate it a buy, 5 hold, and 1 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.
Is AstraZeneca PLC profitable?
AstraZeneca PLC generated $42.85B in revenue during fiscal year 2026, with $7.46B reaching the bottom line as net income. The net profit margin of 17.4% is solid for its sector.
What is AZN's P/E ratio?
AZN trades at a P/E ratio of 28.62 on trailing earnings of $6.55 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Healthcare sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.